# To Identify HLA-A1101-restricted Peptide Epitopes Derived From Novel Oncoantigens (URLC10, KIF20A, and CDCA1) Applicable for Cancer Vaccine in Singapore

> **NCT01570439** · — · UNKNOWN · sponsor: **National University Hospital, Singapore** · enrollment: 10 (estimated)

## Conditions studied

- Anonymous Donors at Blood Donation Center (NUH)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01570439
- **Lead sponsor:** National University Hospital, Singapore
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** 2014-12
- **Final completion:** —
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2013-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01570439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01570439, "To Identify HLA-A1101-restricted Peptide Epitopes Derived From Novel Oncoantigens (URLC10, KIF20A, and CDCA1) Applicable for Cancer Vaccine in Singapore". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT01570439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*